EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Differential Quantification of Cutibacterium acnes Phylotypes IA and IB / II on Healthy and Acne‐Prone Human Skin

Cecilie Feidenhansl iD, Erinda Rruci iD, Nastassia Knödlseder iD, Hans B Lomholt iD, Holger Brüggemann iD

Experimental Dermatology · 2026

DOI: 10.1111/exd.70347 ↗

At a glance

Journal article in Experimental Dermatology, 2026. Written by Cecilie Feidenhansl and 4 co-authors. Institution: Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark. Major MEDLINE topics: Acne Vulgaris, Skin, Propionibacteriaceae, Propionibacterium acnes. 36 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: LEO Fondet, Kjærsgaard foundation.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cutibacterium acnes is a common skin bacterium that inhabits sebaceous follicles and comprises multiple phylotypes. Healthy skin is colonized by a C. acnes population dominated by phylotypes IA, IB, and II. In acne, this diversity is reduced, with a predominance of phylotype IA. Quantifying C. acnes phylotypes has been challenging due to the lack of specific methods. Here, we developed a droplet digital PCR (ddPCR) assay that separately quantifies phylotype IA and phylotypes IB/II, based on a difference in the hyaluronidase gene. The method was applied to skin swabs from 14 healthy individuals and 14 acne patients. Healthy skin contained nearly equal amounts of IA and IB/II, whereas acne samples showed a 111‐fold predominance of IA over IB/II, due to a marked depletion of IB/II, instead of an increase of IA. After 4–6 months of isotretinoin treatment, C. acnes levels decreased drastically, with phylotype IA reduced by 50‐fold. Twelve to 15 months after treatment, both phylotypes rebounded, although IB/II recovered only partially. Taken together, this ddPCR method can quantitatively distinguish the acne‐dominant phylotype IA from healthy skin‐associated phylotypes IB/II, and is thus a useful tool for skin microbiome studies and specifically for assessing C. acnes dysbiosis in acne.

Subjects

MeSH terms (MEDLINE)

Acne VulgarisSkinPropionibacteriaceaePropionibacterium acnesHumansFemaleIsotretinoinPolymerase Chain ReactionSkin MicrobiomeAdultDermatologic AgentsMaleYoung AdultHyaluronoglucosaminidase

Author keywords

Cutibacterium acnesacne vulgarisdroplet digital PCRisotretinoinskin microbiome

Substances

IsotretinoinDermatologic AgentsHyaluronoglucosaminidase

Authors and institutions

  • Department of Biomedicine, Faculty of Health, Aarhus University, Aarhus, Denmark.
  • Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Clinical Institute, Aalborg University, Aalborg, Denmark.

ORCID profiles: Cecilie Feidenhansl, Erinda Rruci, Nastassia Knödlseder, Hans B Lomholt, Holger Brüggemann

Funding

  • LEO Fondet
  • Kjærsgaard foundation

Cite

APA

Feidenhansl, C., Rruci, E., Knödlseder, N., Lomholt, H. B., & Brüggemann, H. (2026). Differential Quantification of Cutibacterium acnes Phylotypes IA and IB / II on Healthy and Acne‐Prone Human Skin. Experimental Dermatology. https://doi.org/10.1111/exd.70347

Vancouver

Feidenhansl C, Rruci E, Knödlseder N, Lomholt HB, Brüggemann H. Differential Quantification of Cutibacterium acnes Phylotypes IA and IB / II on Healthy and Acne‐Prone Human Skin. Experimental Dermatology. 2026. doi:10.1111/exd.70347

BibTeX
@article{Feidenhansl2026,
  author = {Feidenhansl, Cecilie and Rruci, Erinda and Knödlseder, Nastassia and Lomholt, Hans B and Brüggemann, Holger},
  title = {Differential Quantification of Cutibacterium acnes Phylotypes IA and IB / II on Healthy and Acne‐Prone Human Skin},
  journal = {Experimental Dermatology},
  year = {2026},
  doi = {10.1111/exd.70347}
}
Start for free →